Project Number 5R01AG057909-05 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Resilience to Alzheimer's disease in humans with exceptional longevity Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 13. Molecular Mechanisms of Neuroprotection and Resilience Researcher and Organization Principal Investigator BARZILAI, NIR J Principal Investigator First Name NIR J Principal Investigator Last Name BARZILAI Awardee Organization ALBERT EINSTEIN COLLEGE OF MEDICINE Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-17-061: Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimers Disease Risk (R01) FY Overall Cost $1,244,549 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Target Discovery and Preclinical Validation Project Related Resources Repository [Resilience-AD] Resilience to Alzheimers disease in humans with exceptional longevity
